Today@Dal

» Go to news main

Canadian Center for Vaccinology RSV vaccine studies

Posted by Pediatrics/Canadian Center for Vaccinology on October 2, 2019 in General Announcements

​RSV (respiratory syncytial virus) is a germ that can cause airway infections. Most RSV infections result in a simple cold, however RSV infections can be more serious in young babies, whose airways are still very small and whose immune system cannot fight germs very well.

RSV is the most common cause of bronchiolitis (infection of the breathing tubes) and some pneumonia (lung infection) in young infants. Severe RSV in young babies can cause wheezing and asthma in childhood.

This study will try to find out if the study vaccine against RSV is safe and may protect infants against RSV.

Participants must be healthy, between 6 and 7 months of age and not have had a documented/confirmed RSV infection or symptoms. They must have been born after 37 weeks and before 42 weeks gestation with a minimum birthweight of 2.5kg (or approximately 5lbs, 8oz).

For more information, visit our website here: http://centerforvaccinology.ca/study/rsv-study/

Contact information: Cathy Brown
902-470-7015
 catherine.brown@iwk.nshealth.ca

--------

RSV is a germ that can cause airway infections. Most RSV infections just result in symptoms similar to a simple cold (such as a runny nose, sneezing and cough). However, RSV infection can be more serious in young babies, whose airways are still very small and whose immune system cannot fight germs very well. RSV is the cause of most bronchiolitis (infection of the breathing tubes causing wheezing) and some pneumonia (lung infection) in young infants. It is estimated that 31 babies out of 1000 under 6 months of age need to be admitted to hospital because of RSV, making it the most common reason for babies to be admitted to hospital in the first year of life.

The primary purpose of this study is to determine the safety and effectiveness of a study vaccine in the prevention of RSV. We are looking for healthy children between 12 and 24 months old to take part in this clinical research study.

For more information, visit our website here: http://centerforvaccinology.ca/study/rsv-study-2/